Back to Search
JAMES HERNDON, M.D.
M.D.
Specialist
NPI: 1831285915Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
D2112(TX)
Research & Publications (20)
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma.
PMID 19562254·J Neurooncol·2010
3-trial
Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma.
PMID 19204199·J Clin Oncol·2009
3-trial
Predictors of success on the American Board of Orthopaedic Surgery examination.
PMID 19557490·Clin Orthop Relat Res·2009
8-other
Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.
PMID 19533023·J Neurooncol·2009
3-trial
Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy.
PMID 19514083·Cancer·2009
8-other
"Reproductive aging in captive and wild common chimpanzees: factors influencing the rate of follicular depletion," by S. Atsalis and E. Videan, American Journal of Primatology 71, 271-282 (2009).
PMID 19514043·Am J Primatol·2009
7-preclinical
Cancer surveillance behaviors and psychosocial factors among long-term survivors of breast cancer. Cancer and Leukemia Group B 79804.
PMID 19133656·Cancer·2009
8-other
Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma.
PMID 19402172·Cancer·2009
3-trial
Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/Tablet data-collection system in academic oncology.
PMID 19394793·J Pain Symptom Manage·2009
3-trial
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma.
PMID 19289491·Neuro Oncol·2009
3-trial
Medical errors in orthopaedics. Results of an AAOS member survey.
PMID 19255214·J Bone Joint Surg Am·2009
8-other
Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma.
PMID 19248046·Cancer·2009
3-trial
Patient safety in north america: beyond "operate through your initials" and "sign your site".
PMID 19487535·J Bone Joint Surg Am·2009
6-review
Phase II trial of Gliadel plus O6-benzylguanine in adults with recurrent glioblastoma multiforme.
PMID 19188181·Clin Cancer Res·2009
3-trial
Health-related quality of life in long-term breast cancer survivors: differences by adjuvant chemotherapy dose in Cancer and Leukemia Group B study 8541.
PMID 19170232·Cancer·2009
8-other
Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancer.
PMID 19652624·J Thorac Oncol·2009
4-observational
Adverse events after total knee arthroplasty: a national Medicare study.
PMID 19577884·J Arthroplasty·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8230 WALNUT HILL LN, SUITE 500
DALLAS, TX 75231 - Phone
- (214) 739-5821
Quick Facts
- NPI
- 1831285915
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile